%PDF-1.4
%
22 0 obj
<>
endobj
19 0 obj
<>
endobj
48 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-08-05T13:36:14Z
2024-03-28T19:06:29-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T19:06:29-07:00
application/pdf
Heather
2005-431.sept
uuid:2f5b12f4-1dd2-11b2-0a00-3209277d8900
uuid:2f5b12f6-1dd2-11b2-0a00-d30000000000
endstream
endobj
8 0 obj
<>
endobj
9 0 obj
<>
endobj
23 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
54 0 obj
[58 0 R]
endobj
55 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
12 789 587 -785 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.0901 Tw 10 0 0 10 53.5 735.3264 Tm
(achieving full-term in those with no or mild lupus activity )Tj
0.1882 Tw 0 -1.2 TD
(\(p < 0.001\). It remains unclear whether this implies that)Tj
-0.0181 Tw T*
(babies were delivered because of poorly controlled maternal)Tj
0.0986 Tw T*
(disease and/or that active maternal disease translates to an)Tj
0 Tw T*
(unfavorable )Tj
/TT1 1 Tf
0.0936 Tw 5.1186 0 Td
[(in uter)36.9 (o )]TJ
/TT0 1 Tf
0.0937 Tw [0.4 (environment. )54.9 (A)-288.5 (decade ago, Rahman,)]TJ
/TT1 1 Tf
0.00771 Tw -5.1186 -1.2 Td
(et al)Tj
/TT0 1 Tf
0 Tw 7.5 0 0 7.5 71.072 678.6265 Tm
(5)Tj
0.00771 Tw 10 0 0 10 77.3989 675.3264 Tm
(reported that in 73 SLE patients with 141 pregnancies)Tj
0.0379 Tw -2.3899 -1.2 Td
(between 1970 and 1995, renal disease was the only statisti-)Tj
0.22839 Tw T*
(cally significant predictor for fetal loss \(p < 0.012\) and)Tj
0.03999 Tw T*
(hypertension for poor fetal outcome \(p < 0.024\), using uni-)Tj
0.02499 Tw T*
(variate analysis.)Tj
0.0218 Tw 1.2 -1.2 Td
(On the side of optimism, preterm birth might represent a)Tj
0.27921 Tw -1.2 -1.2 Td
(\223rescued baby\224 that would otherwise have been a fetal)Tj
0.283 Tw T*
(demise if not delivered early when biophysical profiles)Tj
0.01781 Tw T*
[(screamed of imminent danger)54.9 (. )17.8 (This optimism notwithstand-)]TJ
0.17039 Tw T*
(ing, preterm infants do not always survive, those that do)Tj
-0.00729 Tw T*
(may have other medical problems, and the cost of caring for)Tj
0.02499 Tw T*
[(these neonates can be extraordinary)64.9 (.)]TJ
0.24519 Tw 1.2 -1.2 Td
(Although the study of Clark, )Tj
/TT1 1 Tf
12.9462 0 Td
(et al)Tj
/TT0 1 Tf
0 Tw 7.5 0 0 7.5 214.9089 534.6265 Tm
(2)Tj
0.24519 Tw 10 0 0 10 223.6108 531.3264 Tm
(did not formally)Tj
-0.00011 Tc 0.10719 Tw -17.0111 -1.2 Td
[(address whether pregnancy adversely af)17.7 (fects maternal dis-)]TJ
0 Tc 0.0994 Tw T*
(ease, the authors do imply in their discussion that patients)Tj
-0.00011 Tc 0.1011 Tw T*
[(who do not have severe or)17.7 (gan disease or a history of life-)]TJ
0 Tc 0.19591 Tw T*
(threatening complications in previous pregnancies should)Tj
0.20129 Tw T*
[(have a favorable course. )17.8 (While this wisdom is generally)]TJ
0.17979 Tw T*
(accepted, it is worthy of mention that Lockshin and col-)Tj
0.07829 Tw T*
(leagues were instrumental in this regard over 20 years ago)Tj
0.164 Tw T*
(when they compared disease activity in pregnant patients)Tj
0.19569 Tw T*
(with SLE and non-pregnant patients matched for disease)Tj
-0.00011 Tc 0 Tw T*
(severity)Tj
0 Tc 7.5 0 0 7.5 85.1504 414.6265 Tm
(6)Tj
0.04269 Tw 10 0 0 10 88.9004 411.3264 Tm
[(. )17.8 (There were no statistically significant dif)17.8 (ferences)]TJ
0.2339 Tw -3.54 -1.2 Td
(in the frequency of any disease activity marker studied,)Tj
0.01221 Tc 0.36279 Tw T*
(including proteinuria, hypocomplementemia, anti-DNA)Tj
0 Tc -0.00909 Tw T*
[(antibodies, and therapy)64.9 (. Few earlier studies evaluating preg-)]TJ
0.02499 Tw T*
(nancy in patients with lupus included control groups.)Tj
0.03461 Tw 1.2 -1.2 Td
(On balance, Clark and her team are appropriate in advo-)Tj
0.24319 Tw -1.2 -1.2 Td
(cating that the conventional description of pregnancy in)Tj
0.0213 Tw T*
[(SLE be replaced by a more optimistic view)64.9 (, with the caveat)]TJ
-0.00011 Tc 0.18069 Tw T*
[(that a history of arterial thrombosis, severe renal insuf)17.7 (fi-)]TJ
0 Tc 0.1315 Tw 26.4 42 Td
[(ciency)64.9 (, and pulmonary hypertension are contraindications.)]TJ
0.1553 Tw T*
[(However)39.8 (, optimism does not obviate the critical need for)]TJ
-0.02631 Tw T*
(judicious obstetrical care and the search for biomarkers such)Tj
0.2095 Tw T*
(as complement activation products [Salmon JE. Personal)Tj
0.22881 Tw T*
(communication \(Re: NIH Grant No. 5R01AR049772-02,)Tj
0.0199 Tc 0.81821 Tw T*
(Predictors of Pregnancy Outcome in SLE and)Tj
0 Tc 0.0657 Tw T*
(Antiphospholipid Syndrome\)] that would help predict poor)Tj
0.07069 Tw T*
(outcomes beyond the influence of maternal disease or spe-)Tj
0.02499 Tw T*
(cific autoantibodies.)Tj
/TT2 1 Tf
-0.00011 Tc 10.1 -2.4 Td
[(JILL)-220.2 (P)91.7 (. BUYON, )]TJ
/TT0 1 Tf
-0.0002 Tc 0 Tw 6 0 0 6 494.7261 615.3264 Tm
(MD,)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 418.5 605.3264 Tm
(Hospital for Joint Diseases,)Tj
0 -1.25 TD
[(New )36.8 (Y)100 (ork University School of Medicine,)]TJ
-0.0118 Tw T*
[(New Y)100 (ork, )-36.8 (New Y)100 (ork, )-36.8 (USA)]TJ
/TT1 1 Tf
0 Tc 0.0249 Tw -12.625 -2.75 Td
[(Addr)36.9 (ess r)36.9 (eprint r)36.9 (equests to Dr)110.8 (. J.P)128.9 (. Buyon, Department of Rheumatology)54.9 (,)]TJ
T*
[(Room 1608, Hospital for Joint Diseases, 301 East 17th Str)36.8 (eet, New Y)91.8 (ork,)]TJ
T*
[(NY 10003. E-mail: jill.buyon@nyumc.or)36.9 (g)]TJ
/TT2 1 Tf
-0.00011 Tc 0 Tw 10 0 0 10 317.5 519.3264 Tm
(REFERENCES)Tj
/TT0 1 Tf
0 Tc 0.0249 Tw 8 0 0 8 324.5 509.3264 Tm
[(1.)-875 (Buyon J, Kalunian K, Ramsey-Goldman R, et al. )54.8 (Assessing disease)]TJ
1.675 -1.25 Td
[(activity in SLE patients during pregnancy)64.9 (. Lupus 1999;8:677-84.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(2.)-875.1 (Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss)]TJ
0 Tc 1.675 -1.25 Td
(rates in patients with systemic lupus over a 40-year period. )Tj
T*
(J Rheumatol 2005;32:1709-12.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (Clowse ME, Magder LS, )17.7 (W)39.7 (itter F)79.7 (, Petri M. )17.7 (The impact of increased)]TJ
0 Tc 1.675 -1.25 Td
[(lupus activity on obstetric outcomes. )54.9 (Arthritis Rheum 2005;)]TJ
0 Tw T*
(52:514-21.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(4.)-875.1 (V)111 (entura SJ, Mosher )17.7 (WD, Curtin SC, )54.8 (Abma JC, Henshaw S. )17.7 (T)34.8 (rends)]TJ
0 Tc 1.675 -1.25 Td
(in pregnancies and pregnancy rates by outcome: estimates for the)Tj
T*
[(United States, 1976-96. National Center for Health Statistics. )17.7 (V)60.1 (ital)]TJ
T*
(Health Stat 21, DHHS Publication No. 2000-1934.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(5.)-875.1 (Rahman P)110.7 (, Gladman DD, Urowitz MB. Clinical predictors of fetal)]TJ
0 Tc 1.675 -1.25 Td
(outcome in systemic lupus erythematosus. J Rheumatol)Tj
0 Tw T*
(1998;25:1526-30.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(6.)-875.1 (Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus)]TJ
0 Tc 1.675 -1.25 Td
[(pregnancy)64.9 (. Case-control prospective study demonstrating absence)]TJ
T*
[(of lupus exacerbation during or after pregnancy)64.9 (. )54.8 (Am J Med)]TJ
0 Tw T*
(1984;77:893-8.)Tj
ET
/CS0 CS 0 0 0 1 SCN
53.46 77 m
558.47 77 l
S
0 0 0 0 scn
52.32 70.16 64.18 -15.66 re
f*
BT
0 0 0 1 scn
/TT1 1 Tf
8 0 0 8 53.3216 57.2343 Tm
(1642)Tj
ET
0 0 0 0 scn
355.5 70.16 203 -15.66 re
f*
BT
0 0 0 1 scn
/TT1 1 Tf
0.02499 Tw 8 0 0 8 423.8613 57.2343 Tm
(The Journal of Rheumatology 2005; 32:9)Tj
ET
0 0 0 0 scn
/GS0 gs
104.09 82.08 407.5 -10.83 re
f*
0.5 w
104.09 82.08 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
43 0 obj
<>
endobj
53 0 obj
<>
endobj
26 0 obj
<>
endobj
31 0 obj
<>
endobj
4 0 obj
<>
endobj
5 0 obj
<>
endobj
6 0 obj
<>stream
HdVpTs͋р,!$^d .R%&yH2H:#(*yH[X0K`ZAS+GM`/?>w0w-*{^`RJ5[@i
]_z
,_s
-w~A}:tMͣ>("h7C=߹,AAV E`L}]Ӟuӊ8ѿ_ݚQ3>OI늶vͧOljM}
ga+B{Q ljz{c"SS&m;aR~ɵNf *\oXrЂL{XMbVg}=Aom&)"߅xOnr{P0n+]LQLGWjZuhŧ
Gýa7SN<eta1Iom9O"Y0\Jڪf<؏^$\H{ݏJN܇-x?R*A5IP{[!Iv
y;#R#7Kt7xmuB$z܃2(NQ3G
%,-ң|!czƵOL,D+{72HL
"RO){֪KYƫfn52Z YWp%ik^f|/1%_.Q1r"U3ZY)O>SI)9&̵V^VSIo0*MRV3.ŽF<.vUF9C,dy-+2T FR-s٧r
#QAOzQ^3Ei!@-R-}18cf|*Z֞,ٕvMwsO#b2\V0v~?6!ғӜ9G/=#wVvCҧ^-aS;ZuR[DfF*6c$+]vq` },0>gT9iuV= R1xe8bfNsyԂUlͶ^7^5u*cLFẆ2O+5M%}9aşPT7E0yJ;SYVg;Xr_ WRm-[NYF7d}q_\4pTH߈˿;$';+32
%(U136cٳzo)?EU8?W3DiR矁2;Gl_PK]wz=jC|%"~GbS*Eh` a6`fֈ:v$ꌴ#ޙQ7:F#`#3a=?UwlsB>ZLj9*}\Pꌰ#Έ_~a;E7:tTIUY?;]|wՋ4:.{*&;%~'ۉ1k
v~DeTnl3o<&0=؍Z&L<뽵=I>bҲ
bSV%